病毒性肝炎总论_培训课件.pptVIP

2. 乙肝的预防 被动免疫：人乙肝高效价免疫球蛋白 主动免疫：基因工程疫苗——已推广 基因疫苗——在研究中 3. 丙肝、丁肝及戊肝疫苗尚出于基础研究阶段 免疫球蛋白的预防效果也不肯定 * Key messages Hepatitis B is one of the most common infectious diseases in the world. There are 350 million chronic carriers of the hepatitis B virus worldwide. Hepatitis B is the ninth leading cause of death worldwide. Geographical prevalence varies widely throughout the world. Nearly 75% of HBV chronic carriers are Asian. Points of explanation The geographical prevalence of hepatitis B varies from a highly endemic disease in Asia and Africa to a disea